Our Investors

At Rallybio, we are focused on identifying and accelerating the development of transformative breakthrough therapies for patients with severe and rare disorders. The company has secured $37.0 million in Series A funding from investors including:

5am Ventures

5AM Ventures is a leading venture capital firm focused on building next-generation life science companies capable of delivering outstanding returns to investors. 5AM Ventures supports companies solving important healthcare needs via cutting-edge breakthroughs in medicine and science. 5AM Ventures portfolio companies spearhead novel approaches to diagnose, prevent and treat a wide range of medical conditions. The firm has offices in Menlo Park, CA and Waltham, MA.

Canaan Partners

Canaan Partners invests in entrepreneurs and works alongside them to turn visionary ideas into valuable companies. Since 1987, the firm has catalyzed the growth of disruptive technology startups and healthcare companies revolutionizing the practice of medicine. Canaan maintains a presence in the global innovation hubs of New York, Silicon Valley and Israel with $5 billion under management and over 190 exits to date.

New Leaf Venture Partners

New Leaf Venture Partners (NLVP) was formed in 2005, when the healthcare team spun out of the Sprout Group. The NLVP team has been built over the last two decades and managed healthcare technology portfolios in four Sprout funds and four New Leaf funds. NLVP partners with companies across all phases, from startup to public offerings, to invest in visionary teams, businesses at the forefront of biology and innovation, and disruptive healthcare technologies across the entire healthcare system. NLVP shares broad perspectives, decades of experience and deep domain expertise to help portfolio companies navigate the complexity of the healthcare industry.

Connecticut Innovations

Connecticut Innovations (CI) is the leading source of financing and ongoing support for Connecticut’s innovative, growing companies. To maximize each business’s growth potential, CI tailors its solutions and often combines its funds with resources from other financial leaders to provide venture capital and strategic support for early stage technology companies; flexible loans and grants that support innovation and collaboration; and connections to its well-established network of partners and professionals. CI has helped bring $4 billion in financing to Connecticut companies.